Furthermore, evodiamine significantly suppressed lactate-induced angiogenesis in prostate cancer cells by limiting histone lactylation and HIF-1α expression, which improved Sema3A transcription while downregulating PD-L1 transcription. This evidence concerns the gene SEMA3A and prostate cancer.